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Abstract 
Porcine bocavirus (PBoV), a newly described porcine parvovirus, has received 
attention because it can be commonly identified in clinically affected pigs including 
pigs with post-weaning multisystemic wasting syndrome (PWMS) and pigs with 
diarrhea. In recent years, novel PBoVs have been identified and were classified into 
three genogroups, but the ability to detect and classify these novel PBoVs is not 
comprehensive to date. In this study, a multiplex conventional PCR assay for 
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simultaneous detection and grouping of PBoVs was developed by screening 
combinations of mixed primer pairs followed by optimization of the PCR conditions. 
This method exclusively amplifies targeted fragments of 531 bp from the VP1 gene of 
PBoV G1, 291 bp from the NP1 gene of PBoV G2, and 384 bp from the NP1/VP1 
gene of PBoV G3. The assay has a detection limit of 1.0 × 103 copies/µL for PBoV 
G1 4.5 × 103 for PBoV G2 and 3.8 × 103 for PBoV G3 based on testing mixed 
purified plasmid constructs containing the specific viral target fragments. The 
performance of the multiplex PCR assay was comparable to that of the single PCRs 
which used the same primer pairs. Using the newly established multiplex PCR assay, 
227 field samples including faeces, serum and tissue samples from pigs were 
investigated. All three PBoV genogroups were detected in the clinical samples with a 
detection rate of 1.3%, 2.6% and 12.3%, respectively for PBoV G1, G2 and G3. 
Additionally, coinfections with two or more PBoV were detected in 1.7% of the 
samples investigated. These results indicate the multiplex PCR assay is specific, 
sensitive and rapid, and can be used for the detection and differentiation of single and 
multiple infections of the three PBoV genogroups in pigs. 
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1. Introduction 
Porcine bocavirus was first discovered in Swedish pigs with post-weaning 
multisystemic wasting syndrome (PMWS) in 2009 and was classified within the 
Bocaparvovirus genus (Blomström et al., 2009; Cadar et al., 2011; Cotmore et al., 
2014). Bocavirus was discovered in both humans and animals and to date includes 
human bocavirus (HBoV) (Allander et al., 2005; Cashman and O’Shea, 2012), 
porcine bocavirus (PBoV) (Blomström et al., 2009), bovine parvovirus (BPV) (Chen 
et al., 1986), minute virus of canines (MVC) (Binn et al., 1970), gorilla bocavirus 
(GBoV) (Kapoor et al., 2010a) and California sea lion bocavirus (CslBoV) (Li et al., 
2011b). Viruses in the Bocaparvovirus genus belong to the subfamily Parvovirinae of 
the Parvoviridae family, which is a group of divergent linear ssDNA viruses (Tijssen 
et al., 2011). Porcine bocavirus has a genome of ~5 kb and has three open reading 
frames that encode four proteins: NS1, NP1, VP1 and VP2 (Choi et al., 2014; Zeng et 
al., 2011; Zhang et al., 2015b). Parvoviruses were demonstrated to have nucleotide 
substitution rates that are as high as those of some RNA viruses (Duffy, Shackelton, 
and Holmes, 2008; Shackelton et al., 2005) and recent results suggest that the 
presently circulating PBoVs exhibit considerable genetic diversity within the same 
sample and between different pigs (Lau et al., 2011; Liu et al., 2014; Shan et al., 2011; 
Zhang et al., 2014). These findings may indicate that these viruses are in the process 
of adaptation and can undergo rapid evolution to generate new genotypes or species. 
Numerous PBoVs have been discovered to date. These PBoVs have been classified 
into three genogroups, named provisionally G1, G2 and G3, based on phylogenetic 
analysis of the NS1, NP1 and VP1/2 coding genes and genomes (Gunn et al., 2015; 
Jiang et al., 2014; Xiao, Halbur, and Opriessnig, 2013; Yang et al., 2012). 
 
Members of the genus Bocaparvovirus are pathogens that have been associated with 
various disease manifestations, including respiratory and enteric diseases (Jiang et al., 
2014). All four genotypes of HBoV have been identified in children with acute 
gastroenteritis, whereas only HBoV1 and HBoV2 were identified in respiratory tract 
samples (Xu et al., 2012a). More recent research strongly supported the hypothesis 
that HBoV can cause severe acute respiratory tract infection in children in the absence 
of viral and bacterial co-infections (Broccolo et al., 2015; Moesker et al., 2015). 
Reports suggest that some PBoVs may be associated with respiratory signs or diarrhea, 
although the pathogenicity of PBoVs has also not been recognized clearly mainly due 
to a lack of a suitable cell culture system or animal model (Blomström et al., 2009; 
Zhai et al., 2010). Therefore, detection and differentiation of PBoV is important to 
better understand the potential associations between PBoVs and related diseases. 
 
Recently, emerging parvoviruses in pigs were discovered through the application of 
random amplification and large-scale sequencing techniques, followed by 
bioinformatic analysis of large numbers of the sequences of the resulting clones 
(Allander et al., 2001; Allander et al., 2005; Shan et al., 2011). With public 
availability of these viral sequences, simple and sensitive PCR methods using specific 
primers have been developed for PBoV (Kapoor et al., 2010b; Lau et al., 2011). 
However, these methods usually focused on G1 of PBoVs mainly due to availabilty of 
limited numbers of reference strains and a consensus PCR assay using one primer pair 
targeting a conserved region to detect all the PBoVs has not been reported yet mainly 
due to the high level of genetic diversity. In addition, conventional PCR technology to 
detect several PBoV genogroups individually is labor-intensive and expensive. These 
limitations can be overcome by using a multiplex conventional PCR assay, which 
incorporates multiple primers that amplify RNA or DNA from several viruses 
simultaneously in a single reaction (Elnifro et al., 2000). 
 
In the present study, a multiplex conventional PCR assay was developed by 
combining three pairs of primers in one reaction. Furthermore, the reaction conditions 
were optimized for the rapid detection and differentiation of PBoV G1, G2, and G3 on 
the basis of amplicon size. To validate its application, we tested this assay for 
specificity and sensitivity on clinical samples and compared the results with those 
obtained by using single PCRs. 
 
2. Materials and methods 
2.1. Viruses and samples 
The following viruses were used and stored in our laboratory: PBoV G1 strain 
MN307 (GenBank Accession number KF025391), PBoV G2 strain IA147 (GenBank 
Accession number KF025392) and PBoV G3 strain IA270 (GenBank Accession 
number KF025390). To test specificity of the assay, the following non-targeted viruses 
were utilized: A commercial porcine parvovirus (PPV) vaccine strain (Beijing 
Zhonghai Animal Health Science and Technology Co., Ltd, China, No. 0040401), 
commercial transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea 
virus (PEDV) vaccine strains (Harbin Weike Biotechnology development company, 
Harbin, China, No. 030718), a classical swine fever virus (CSFV) (Hangzhou strain), 
porcine circovirus type 2 (PCV2) (GenBank Accession Number GQ996404) and 
porcine reproductive and respiratory syndrome virus (PRRSV) (GenBank accession 
number DQ269472). All viruses were maintained in the authors’ laboratory. 
 
A total of 227 pig samples were utilized to test the multiplex PCR. The samples 
included 200 faecal samples from clinically normal pigs located in the Zhejiang 
province and collected during 2013. In addition, 22 serum samples from normal pigs 
and five lung samples from pigs suffering from respiratory tract symptoms or 
reproductive failure were collected in different pig farms in several provinces in 
China during 2013 to 2014. All samples were stored at -80°C until testing. The 
samples used in this study were collected in accordance with international standards 
for animal welfare. 
 
2.2. Primers design 
All genomic sequences of the PBoVs utilized in this study were obtained from the 
GenBank nucleotide sequence database from the National Center for Biotechnology 
Information (NCBI). Highly conserved regions within each PBoV genogroup 
genomes were identified by alignment of all available 62 partial and complete or 
nearly complete genome sequences with Clustal W (DNAStar Inc., Madison, WI, 
USA) (Fig S1). Primers corresponding to these conserved regions of the viral 
genomes were designed using Primer Premier 5.0 (Primer Biosoft International, Palo 
Alto, CA, USA). Three pairs of primers were designed to amplify PBoV G1, PBoV 
G2 or PBoV G3 and are outlined in Table 1. The specificity of the primers was 
confirmed against random nucleotide sequences obtained by a BLAST search in the 
GenBank database. All primers were obtained from a commercial source (Sangon 
Biotech. Co., Ltd, Shanghai, China). 
 
2.3. Nucleic acid extraction 
The samples were processed as described previously (Jiang et al., 2014). Briefly, 
tissue samples were minced and diluted 1:10 (w/v) in Dulbecco’s modified Eagle’s 
medium, homogenized and centrifuged at 1500 g for 10 min to obtain the supernatant. 
Faecal samples were resuspended 1:10 (w/v) in PBS, vortexed for 30 s and 
centrifuged at 1500 g for 10 min. Viral genomic DNA was extracted from frozen 
clinical samples using the AxyPrepTM Body Fluid Viral DNA/RNA Miniprep Kit 
50-prep (Axygen, Hangzhou, China) according to the manufacturer's instructions. The 
extracted DNA was stored at -80°C until use. 
 2.4. Single PCR and plasmid template construction 
The PCR reaction for PBoV G1, G2 and G3 was conducted in a 25 µL mixture 
including 2.5 µL 10× PCR buffer, 1.2 µL 2.5 mM of each dNTPs, 2.5 µL 25 mM 
MgCl2, 0.5 µL of each 10 µM primer (Table 1), 1.5 U of Taq DNA polymerase (5 
U/µL) (Sangon), 2 µL of the DNA and 16 µL distilled water. The amplifications were 
performed in a thermal cycler (Bio-Rad Laboratories, Hercules, CA, USA) under the 
following conditions: after initial denaturation at 95°C for 3 min, 35 cycles were 
conducted at 94°C for 30 s, 56°C for 30 s and 72°C for 30 s, followed by a final 
extension at 72°C for 10 min. The amplicons were detected by electrophoresing 5 µL 
aliquots through 1.5% agarose gel in 1×TAE (40 mM Tris-aceate [pH 8.0], 1 mM 
EDTA). Each specific viral target fragment was cloned into the plasmid pMD18-T 
(TaKaRa), and then sequenced and confirmed the constructed recombinant plasmids 
which were used as standard templates for optimization of the following PCR assays. 
 
2.5. Optimization of the multiplex PCR assay 
Based on the established single PCRs, a series of experiments were performed to 
optimize the multiplex PCR protocol, including reagent concentration and PCR 
cycling parameters. The multiplex PCR was carried out in a 20 µL reaction mixture 
consisting of 2 µL of 10× PCR Buffer, 0.1 to 6 mM MgCl2, 0.01 to 0.6 mM dNTP mix, 
0.5 to 6 U Taq DNA polymerase, 2 µL of each plasmid DNA, and 0.05 to 0.6 mM 
each primer pair of three PBoV genogroups. The amplification was run in a Bio-Rad 
thermal cycler (Laboratories, Hercules, CA, USA) under the following conditions: 
initial denaturation at 95°C for 5 min, 35 cycles of denaturation at 94°C for 30 s; 
annealing at 55-60°C for 30 s and elongation at 72°C for 30 s, followed by a final 
extension at 72°C for 10 min. Amplicons were detected by electrophoresing 5 µL 
aliquots through 1.5% agarose gel in 1×TAE buffer. Negative controls using distilled 
water instead of template DNA were run with each test.  
 
2.6 Assay specificity of the multiplex PCR 
The specificity of the multiplex PCR assay was verified by examining DNA/cDNA 
from the positive and negative controls. The size-specific PCR products (531, 291 and 
384 bp) obtained were analyzed by electrophoresing, and the sequence identity was 
checked against sequences deposited in the GenBank using a BLAST search at NCBI 
site. 
 
2.7 Assay sensitivity of the single PCR and multiplex PCR 
In order to test and compare the sensitivity of the multiplex PCR versus single PCR, 
each specific viral target DNA fragment was cloned into the plasmid pMD18-T and 
served as template using a 10-fold dilution series. The number of gene copies per µL 
in each dilution was calculated by using the formula: copies/µL= (6.02 × 1023) × 
Plasmid concentration (ng/µL) × 10-9/[(Plasmid length (bp)× 660]. 
 2.8. Detection of PBoV G1, G2 and G3 in clinical specimens by the single and 
multiplex PCR 
A total of 227 clinical specimens from pig farms in China were tested for PBoV G1, 
G2 and G3 by each single PCR and also by the combined multiplex PCR assay. Each 
specific viral target fragment was cloned into the plasmid pMD18-T and sequenced by 
Shanghai Sangon Biotechnology Co., Ltd. 
 
3. Results 
3.1. Optimization of the multiplex PCR 
After optimization, the multiplex PCR produced amplicons of 531 bp for PBoV G1, 
291 bp for PBoV G2 and 384 bp for PBoV G3 with clear and similar fluorescence 
intensity. The optimal annealing temperature was 56°C. Other optimal conditions 
determined for the multiplex PCR were as follows: a MgCl2 concentration of 2.5 mM, 
a primer concentration of 0.2 µM for PBoV G1, 0.1 µM for PBoV G2 and 0.2 µM for 
PBoV G3, dNTP concentrations of 0.2 mM, and 2.5 U Taq DNA polymerase. 
 
3.2. Specific detection of PBoV G1, G2 and G3 in the multiplex PCR assay 
The multiplex PCR assay was able to detect and differentiate PBoV G1, G2 and G3 
independently. When different combinations of the three PBoV group viruses were 
used in the multiplex PCR, the corresponding amplicons were produced and 
confirmed by sequencing (Fig. 1). In contrast, no amplicons were produced with the 
negative controls, which included PPV, PCV2, PRRSV, CSFV, TGEV, PEDV and 
ddH2O (Fig. 1). These results indicate that the multiplex PCR assay was specific for 
detection and differentiation of the three main PBoV genogroups. 
 
3.3. Sensitivity of the single PCR and multiplex PCR assays 
The sensitivity of the single PCR assays were 1.0 × 103 genomic copies/µL of PBoV 
G1, 4.5 × 103 copies/µL of PBoV G2 and 3.8 × 103 copies/µL for PBoV G3 (Fig. 
2A-C). The multiplex PCR assay was also able to detect at least 1.0 × 103 genomic 
copies/µL of PBoV G1, 4.5 × 103 copies/µL of PBoV G2 and 3.8 × 103 copies/µL for 
PBoV G3 (Fig. 2D). 
 
3.4. Application of the multiplex PCR assay for clinical samples 
To validate the multiplex PCR for diagnosis of PBoVs, 227 clinical specimens were 
tested for the three PBoV groups using the single and multiplex PCR assay and DNA 
sequencing of PCR positive products (Table 2). Among all samples 31/227 (13.7%) 
was tested positive by the multiplex PCR assay, which was slightly lower than 32/227 
(14.1%) positive samples by the single PCRs. The detection rates were 1.3% for 
PBoV G1, 2.6% for PBoV G2 and 12.3% for PBoV G3. In addition, among the 227 
samples, co-infection by PBoV G1 and PBoV G3 was detected in 0.4% of the samples, 
coinfection of PBoV G2 and PBoV G3 was detected in 0.9% of all samples and, all 
three PBoV genogroups were detected in 0.4% of the samples. Moreover, a higher 
prevalence rate of PBoVs (15%, 30/200 samples) was detected in faecal samples 
compared with serum (4.5%, 1/22 samples) and lung samples (0%, 0/5). 
 
4. Discussion 
Over the past six years, with increased availability of improved methods and 
techniques, the research on PBoV has expanded rapidly. Nevertheless, some questions 
remain unsolved. Previous PBoV DNA prevalence data depended on primer design 
using sequences of limited reference strains published in NCBI at that time, which 
was not comprehensive and may have resulted in non-ideal primer choices and false 
negative samples (Cadar et al., 2011; Lau et al., 2011; Li et al., 2011a; Shan et al., 
2011; Yang et al., 2012; Zhai et al., 2010). To elucidate the biological characteristics 
and even the possible cross-species transmission of PBoVs and human BoVs, 
detection and further study of diverse PBoVs was necessary. A multiplex PCR has the 
potential to save substantial time, effort and reagent cost (Liu et al., 2013). In addition, 
it reduces the sample amount required for the assay, which is particularly important 
when sample material is limited. In order to detect all PBoVs infecting pigs using a 
single tool, a multiplex TaqMan real-time PCR assay has been recently described 
(Jiang et al., 2014). However, probe-based assays are expensive and highly influenced 
by the potential presence of mutations within the probe-binding site that can prevent 
annealing of the probe and subsequent detection (Zheng et al., 2012). In this study, a 
multiplex PCR method based on PBoV sequences described up to 2016 was 
successfully developed to detect and differentiate PBoV G1, G2 and G3 in samples 
from pigs with single or multiple infections. 
 
The development of a multiplex PCR method is a complex task mainly due to the fact 
that the presence of more than one primer pair in the same reaction mix may limit the 
sensitivity or specificity or cause preferential amplification of specific targets (Elnifro 
et al., 2000; Markoulatos, Siafakas, and Moncany, 2002). The sensitivity of the 
multiplex PCR is usually approximately 10 fold lower than that of a single PCR (Xu 
et al., 2012b). However, the established multiplex PCR assay in the current study was 
as sensitive as the single PCR with a detection limit of 1.0 × 103, 4.5 × 103, and 3.8 × 
103 copies/µL for PBoV G1, G2, and G3, respectively, indicating minimal interference 
among primers. Furthermore, the sensitivity was similar to that of a single PCR (103 
copies/µL) (Liu et al., 2013) and a probe-based multiplex real-time PCR which had a 
detection limit around 600 copies/L for PBoV G2 (Jiang et al., 2014). This may 
suggest an ideal primer design and proper reaction optimization of the multiplex assay 
developed in this study, thus avoiding the possible formation of primer dimers among 
different targets in one reaction. These overall obtained results indicate that the 
multiplex PCR assay established here was sensitive for detection of all PBoV 
genogroups. 
 
Clinical samples may contain PCR inhibitors, which may be carried over during 
nucleic acid extraction and which can result in a reduction of the sensitivity of an 
assay potentially leading to inaccurate quantitative results or even false negative 
results (Hoorfar et al., 2004; Nolan et al., 2006). To account for this some PCR assays, 
mainly real time PCRs, have been developed to monitor sample extraction and 
amplification inhibitors by using an internal positive control (Auburna et al., 2011; Pal 
et al., 2008; Xiao et al., 2009). However, identification of PCR inhibitors was very 
limited in these studies. For example, only 2 of 1265 (0.2%) nasopharyngeal samples 
showed evidence of inhibition of amplification of the internal control in a multiplex 
real time PCR assay (Auburna et al., 2011). On the other hand, addition of an internal 
control increases the difficulty to optimize a multiplex assay and could compromise 
the sensitivity and specificity. Internal positive controls were therefore not included in 
this study. 
 
To guarantee the specificity of the multiplex PCR, specific primers were designed in 
the highly conserved regions for each PBoV genogroup which were divergent among 
the three genogroups (Fig S1). The specific primers produced distinct PCR products 
for each PBoV group, which can be visualized and easily differentiated by 1.5% 
agarose gel electrophoresis. In addition, no amplification occurred with non-target 
viruses or ddH2O, indicating that the multiplex PCR assay was specific for detection 
of the three targeted PBoV genogroups. Moreover, to verify the results of the 
multiplex PCR protocol, all the size-specific PCR products obtained by analyzing the 
clinical specimens were cloned into the plasmid pMD18-T and sequenced. The result 
of the BLAST analysis for these sequences indicated the identities of these 
size-specific PCR products, further confirming the specificity of the multiplex assay. 
  
The multiplex PCR as an alternative laboratory method to standard PCR was 
evaluated in the current study. Two hundred and twenty-seven field samples were 
tested for the presence of the three PBoV genogroups and the result of the multiplex 
PCR was compared to that obtained by a standard PCR method. The results were 
identical, except for one sample that was tested positive for PBoV G2 by the single 
PCR, but negative by the multiplex PCR.  
 
Among pig field samples tested, PBoV displayed an overall prevalence rate of 14.1%. 
This is similar to previous studies which reported that 12.59% (50/397) (Cheng et al., 
2010), 11.4% (46/403) (Zhang et al., 2015a) and 16.5% (55/333) (Lau et al., 2011) of 
Chinese pigs samples were positive. Among the genogroups, PBoV G1, G2 and G3 
had been reported to have varying prevalence rates ranging from 1.5 to 88% for G1, 
4.8 to 64.4% for G2 and 8.7 to 81.3% for G3 in pig herds from different countries 
including China (Jiang et al., 2014; Xiao, Halbur, and Opriessnig, 2013; Zhang et al., 
2015a). In the current study, the detection rate of PBoV G1, G2 and G3 was 1.3%, 
2.6% and 12.3%, respectively. The variations in prevalence rates for each PBoV 
genogroup may be due to the differences in age of the pigs sampled, the source of 
samples and the detection limit of these assays. Nonetheless, similar to a previous 
study conducted in the American pig population, PBoV G3 was also the most 
frequently detected group circulating in Chinese pig herds, and coinfections of PBoV 
G1/G2, PBoV G1/G3, PBoV G2/G3 or PBoV G1/G2/G3 have also been demonstrated 
in a significant proportion of field cases (Jiang et al., 2014). The data obtained in the 
present study further confirm that co-infections with two or three PBoV groups are 
common in Chinese pigs. 
 
In summary, the multiplex PCR assay described here provides a simple and sensitive 
tool for rapid detection of single as well as mixed infections of PBoV G1, G2 and G3, 
which are common in many pig herds. Therefore, this method could be a good 
alternative for routine molecular diagnosis or extensive epidemiological surveillance 
of PBoV in diagnostic laboratories. 
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Table 1. Primers information for PBoV detection 
Primer Primer sequence (5´→3´) Expected 
product (bp) 
Target gene Position Reference 
sequence 
PBoV 
G1-F 
AATACCCATACTCACAAAG 531 VP1 3991-4521 HQ291308 
PBoV 
G1-R 
GTGATTGATTCATTGCTG 
    
PBoV 
G2-F 
TCCACTGCTTCGAGAACATC 291 NP1 2519-2809 HM053693 
PBoV 
G2-R 
TTCCCTGACATCTTTCCATT 
    
PBoV 
G3-F 
GAAATGTTAGAAGCTGTTGA 384 NP1/VP1 3098-3481  NC_016031 
PBoV 
G3-R 
TACAGGTGACGTTTATTGC 
    
 
 
Table 2. Frequency of viruses alone or in combination in 200 faecal samples from clinically 
normal pigs, 22 serum samples from healthy pigs and 5 tissue samples from clinically sick pigs 
collected from July 2013 to June 2014 
Method Sample 
Type 
Health 
statusa 
No. 
samples 
G1 [no. 
positive 
(%)]b 
G2 [no. 
positive 
(%)]b 
G3 [no. 
positive 
(%)]b 
G1 + G2 
[no. 
positive 
(%)] 
G1 + G3 
[no. 
positive 
(%)] 
G2 + G3 
[no. 
positive 
(%)] 
G1+ 
G2+ G3 
[no.posit
ive (%)] 
Total 
[no. 
positive 
(%)] 
 
Multiplex 
PCR 
Faeces H 200 1(0.5) 2(1) 23(11.5) 0(0) 1(0.5) 2(1) 1(0.5) 30(15) 
Serum H 22 0(0) 0(0) 1(4.5) 0(0) 0(0) 0(0) 0(0) 1(4.5) 
lung D 5 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 
Total 
 
227 1(0.4) 2(0.9) 24(10.6) 0(0) 1(0.4) 2(0.9) 1(0.4) 31(13.7) 
 
Singleplex 
PCR 
Faeces H 200 3(1.5) 6(3) 27(13.5)     31(15.5) 
Serum H 22 0(0) 0(0) 1(4.5)     1(4.5) 
Lung D  5 0(0) 0(0) 0(0)     0(0) 
Total  227 3(1.3) 6(2.6) 28(12.3)     32(14.1) 
a
 H represents healthy; D represents diseased. 
b
 G1, G2 and G3 represent PBoV G1, PBoV G2 and PBoV G2, respectively. 
Fig. 1. Specificity of the multiplex polymerase chain reaction (PCR) assay developed for the 
detection of PBoV G1, G2 and G3. Agarose gel showing simultaneous multiplex PCR 
amplification of different combinations of viral genogroupes with the three sets of primers. 
Fig. 2. Sensitivity of the single PCR assays for each PBoV genogroup (A, B and C) and the 
multiplex PCR for simultaneous amplification of the three PBoV genogroups (D). M: DL2000 
DNA Marker. Lanes 1-7 are 1: 106 copies/µL; 2: 105 copies/µL; 3: 104 copies/µL; 4: 103 copies/µL; 
5: 102 copies/µL; 6: 101 copies/µL; and 7: 100 copies/µL. 
Fig S1 Primer position of three PBoV groups demonstrated by alignment of partial and complete 
or nearly complete genome sequences available in GenBank. 
 
 
 
 
 
 
 
 
 
 
